BioXcel Therapeutics logo

BioXcel Therapeutics

BTAI | NASDAQ
Chart Builder DCF Calculator
$0.18
-$0.54 (-74.96%)
At close: Aug 28, 2026, 4:00 PM ET
-74.96%

Rating

Updated: Aug 27, 2026
46
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $5.6M
1D Range
0.16 0.22
52W Range
0.16 4.29

Valuation (TTM)

PE -0.04
PB -0.05
EV/EBITDA -1.83

Valuation (NTM)

Forward PE N/A
Forward PEG N/A
Price Target $12.00
Loading financial charts...

Profile

BioXcel Therapeutics, Inc. is a biopharmaceutical firm that has reached the commercial phase, distinguishing itself by leveraging artificial intelligence to advance the creation of transformative ther...

Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Mar 8, 2018
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Aug 13, 2026
EPS
-$0.49
Beat +3.92%
REV
$182K
Beat +7.53%
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Hold
Price Target
$4.50
Upside
+2380.71%
Buy (1)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.